The causative agents in infective endocarditis: a systematic review comprising 33,214 cases CT Vogkou, NI Vlachogiannis, L Palaiodimos, AA Kousoulis European journal of clinical microbiology & infectious diseases 35 (8), 1227 …, 2016 | 190 | 2016 |
The Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease: JACC Focus Seminar DA Stakos, K Stamatelopoulos, D Bampatsias, M Sachse, E Zormpas, ... Journal of the American College of Cardiology 75 (8), 952-967, 2020 | 142 | 2020 |
DNA damage response and oxidative stress in systemic autoimmunity VL Souliotis, NI Vlachogiannis, M Pappa, A Argyriou, PA Ntouros, ... International Journal of Molecular Sciences 21 (1), 55, 2019 | 89 | 2019 |
Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery C Lazaridis, NI Vlachogiannis, C Bakogiannis, I Spyridopoulos, ... Hellenic Journal of Cardiology 61 (6), 381-395, 2020 | 65 | 2020 |
Increased adenosine-to-inosine RNA editing in rheumatoid arthritis NI Vlachogiannis, A Gatsiou, DA Silvestris, K Stamatelopoulos, ... Journal of autoimmunity 106, 102329, 2020 | 57 | 2020 |
Adenosine-to-inosine RNA editing in health and disease A Gatsiou, N Vlachogiannis, FF Lunella, M Sachse, K Stellos Antioxidants & Redox Signaling 29 (9), 846-863, 2018 | 52 | 2018 |
Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease NI Vlachogiannis, M Sachse, G Georgiopoulos, E Zormpas, D Bampatsias, ... Journal of molecular and cellular cardiology 160, 111-120, 2021 | 46 | 2021 |
Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus systemic lupus erythematosus PA Ntouros, NI Vlachogiannis, M Pappa, A Nezos, CP Mavragani, ... Clinical Immunology 229, 108765, 2021 | 40 | 2021 |
Association between DNA damage response, fibrosis and type I interferon signature in systemic sclerosis NI Vlachogiannis, M Pappa, PA Ntouros, A Nezos, CP Mavragani, ... Frontiers in immunology 11, 582401, 2020 | 38 | 2020 |
The role of insulin-like growth factor-1 signaling pathways in uterine leiomyoma E Gkioka, P Msaouel, A Philippou, NI Vlachogiannis, CT Vogkou, ... in vivo 29 (6), 637-649, 2015 | 33 | 2015 |
The role of the androgen receptor signaling in breast malignancies PF Christopoulos, NI Vlachogiannis, CT Vogkou, M Koutsilieris Anticancer research 37 (12), 6533-6540, 2017 | 32 | 2017 |
Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptations MP Yavropoulou, MG Filippa, A Mantzou, F Ntziora, M Mylona, ... Endocrine 75 (2), 317-327, 2022 | 30 | 2022 |
The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection NI Vlachogiannis, KM Verrou, K Stellos, PP Sfikakis, D Paraskevis Clinical Immunology 226, 108699, 2021 | 30 | 2021 |
DNA damage accumulation, defective chromatin organization and deficient DNA repair capacity in patients with rheumatoid arthritis VL Souliotis, NI Vlachogiannis, M Pappa, A Argyriou, PP Sfikakis Clinical Immunology 203, 28-36, 2019 | 29 | 2019 |
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 K Stamatelopoulos, G Georgiopoulos, KF Baker, G Tiseo, D Delialis, ... Scientific reports 11 (1), 20239, 2021 | 28 | 2021 |
Additive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis A Gatsiou, G Georgiopoulos, NI Vlachogiannis, L Pfisterer, A Fischer, ... Atherosclerosis 327, 49-58, 2021 | 28 | 2021 |
Cadherin-11 as a therapeutic target in chronic, inflammatory rheumatic diseases PP Sfikakis, NI Vlachogiannis, PF Christopoulos Clinical Immunology 176, 107-113, 2017 | 28 | 2017 |
Distinct transcriptional profile of blood mononuclear cells in Behçet’s disease: insights into the central role of neutrophil chemotaxis KM Verrou, NI Vlachogiannis, G Ampatziadis-Michailidis, P Moulos, ... Rheumatology 60 (10), 4910-4919, 2021 | 22 | 2021 |
Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic system L Liberale, A Akhmedov, NI Vlachogiannis, NR Bonetti, V Nageswaran, ... Cardiovascular research 117 (10), 2275-2288, 2021 | 22 | 2021 |
Increased frequency of the PTPN22W* variant in primary Sjogren's syndrome: association with low type I IFN scores NI Vlachogiannis, A Nezos, AG Tzioufas, M Koutsilieris, ... Clinical Immunology 173, 157-160, 2016 | 21 | 2016 |